{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:23:11Z","timestamp":1792426991280,"version":"4.5.0"},"reference-count":67,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008561","name":"Burnet Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern AIDS Soc"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gay and bisexual men (<jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content>) are at increased risk of hepatitis C\/<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> co\u2010infection. In Australia, the availability of subsidized direct\u2010acting antiviral treatment for hepatitis C has rendered eliminating co\u2010infection possible. High reinfection rates in subgroups with continued exposure may compromise elimination efforts. To inform the development of hepatitis C risk reduction support in <jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content>, we explored reinfection risk perceptions and attitudes among <jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content> living with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> recently cured from hepatitis C.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between April and August 2017, 15 GBM living with diagnosed HIV were recruited from high caseload <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> primary care services in Melbourne following successful hepatitis C treatment. In\u2010depth interviews were conducted exploring understandings of hepatitis C risks, experiences of co\u2010infection and attitudes towards reinfection. Constructivist grounded theory guided data aggregation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants\u2019 understandings of their hepatitis C infection and reinfection trajectories were captured in three categories. <jats:italic>Hepatitis C and <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> disease dichotomies:<\/jats:italic> Hepatitis C diagnosis was a shock to most participants and contrasted with feelings of inevitability associated with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> seroconversion. While <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> was normalized, hepatitis C was experienced as highly stigmatizing. Despite injecting drug use, interviewees did not identify with populations typically at risk of hepatitis C. <jats:italic>Risk environments and avoiding reinfection<\/jats:italic>: Interviewees identified their social and sexual networks as risk\u2010perpetuating environments where drug use was ubiquitous and higher risk sex was common. Avoiding these risk environments to avoid reinfection resulted in community disengagement, leaving many feeling socially isolated. <jats:italic>Hepatitis C care as a catalyst for change<\/jats:italic>: Engagement in hepatitis C care contributed to a better understanding of hepatitis C risks. Interviewees were committed to applying their improved competencies around transmission risk reduction to avoid reinfection. Interviewees also considered hepatitis C care as a catalyst to reduce their drug use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hepatitis C\/<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> co\u2010infection among <jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content> cannot be understood in isolation from co\u2010occurring drug use and sex, nor as separate from their <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection. Hepatitis C prevention must address subcultural heterogeneity and the intersectionality between multiple stigmatized social identities. Hepatitis C care presents an opportunity to provide support beyond cure. Peer support networks could mitigate social capital loss following a commitment to behaviour change and reduce hepatitis C reinfection risks.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jia2.25288","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T08:59:48Z","timestamp":1558429188000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hepatitis C risk perceptions and attitudes towards reinfection among <scp>HIV<\/scp>\u2010diagnosed gay and bisexual men in Melbourne, Australia"],"prefix":"10.1002","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8611-7346","authenticated-orcid":false,"given":"Sophia E","family":"Schroeder","sequence":"first","affiliation":[{"name":"Disease Elimination Program Burnet Institute Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Higgs","sequence":"additional","affiliation":[{"name":"Disease Elimination Program Burnet Institute Melbourne Australia"},{"name":"Department of Public Health La Trobe University Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Winter","sequence":"additional","affiliation":[{"name":"Disease Elimination Program Burnet Institute Melbourne Australia"},{"name":"Department of Gastroenterology and Hepatology St Vincent's Hospital Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Public Health La Trobe University Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Pedrana","sequence":"additional","affiliation":[{"name":"Disease Elimination Program Burnet Institute Melbourne Australia"},{"name":"School of Public Health and Preventive Medicine Monash University Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[{"name":"Disease Elimination Program Burnet Institute Melbourne Australia"},{"name":"School of Public Health and Preventive Medicine Monash University Melbourne Australia"},{"name":"Department of Infectious Diseases The Alfred Hospital Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Doyle","sequence":"additional","affiliation":[{"name":"Disease Elimination Program Burnet Institute Melbourne Australia"},{"name":"School of Public Health and Preventive Medicine Monash University Melbourne Australia"},{"name":"Department of Infectious Diseases The Alfred Hospital Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stoov\u00e9","sequence":"additional","affiliation":[{"name":"Disease Elimination Program Burnet Institute Melbourne Australia"},{"name":"Department of Infectious Diseases The Alfred Hospital Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"e_1_2_10_2_1","volume-title":"Global Hepatitis Report 2017","author":"World Health Organization","year":"2017"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00485-5"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02719.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000834"},{"issue":"28","key":"e_1_2_10_6_1","first-page":"945","article-title":"Sexual transmission of hepatitis C virus among HIV\u2010infected men who have sex with men\u2013New York City, 2005\u20102010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3281053a0c"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.006"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02305.x"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000044"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.004"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000171412.61360.f8"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/689671"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282ef3873"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.038182"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.10556"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1357034X09347221"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0193945907302771"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdv002"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000378"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2013.832721"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1071\/SH12179"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12333"},{"key":"e_1_2_10_24_1","unstructured":"World Health Organization.Key facts on hepatitis C treatment Essential medicines and health products.2016[cited 2016 Oct 27]. Available from:http:\/\/www.who.int\/medicines\/areas\/access\/hepCtreat_key_facts\/en\/"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.4.19500"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00114-9"},{"key":"e_1_2_10_27_1","volume-title":"Monitoring hepatitis C treatment uptake in Australia","author":"The Kirby Institute","year":"2017"},{"key":"e_1_2_10_28_1","unstructured":"Turnbull Government Invests over $1 billion to Cure HEP C [press release]. 20. December2015."},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12550"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30075-9"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000179"},{"key":"e_1_2_10_32_1","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"World Health Organization","year":"2016"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25059"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1471355"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.012"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32836381cc"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.10.027"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.05.003"},{"key":"e_1_2_10_39_1","first-page":"545","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta\u2010analysis","volume":"133","author":"Platt L","year":"2017","journal-title":"Addiction"},{"key":"e_1_2_10_40_1","volume-title":"Constructing grounded theory: a practical guide through qualitative analysis","author":"Charmaz K","year":"2006"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732304266795"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.7748\/nr.21.5.8.e1208"},{"key":"e_1_2_10_43_1","unstructured":"ClinicalTrials.gov.Identifier NCT02786758 Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co\u2010infected Individuals (co\u2010EC): U.S. National Library of Medicine;2016[cited 2017 Sep 21]. Available from:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02786758?term=NCT+02786758&rank=1"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw075"},{"key":"e_1_2_10_45_1","unstructured":"U.S. National Library of Medicine.Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co\u2010infected Individuals (co\u2010EC) ClinicalTrials.gov.2016[cited 2017 Sep 23]. Available from:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02786758"},{"key":"e_1_2_10_46_1","first-page":"271","volume-title":"The discovery of grounded theory : strategies for qualitative research","author":"Glaser BG","year":"1967"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(17)30852-8"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.15.5.369.23822"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0180-7"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/009145090403100303"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540120500330554"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.2174\/157016209789973655"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/13691050802061673"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(14)70001-3"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.03.014"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12574"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.01.006"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit263"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.74.4.909"},{"key":"e_1_2_10_60_1","unstructured":"AllportGW.The nature of prejudice: Cambridge MA: Addison\u2010Wesley (text ed.); Boston: Beacon Pr. (trade ed.);1954."},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28769"},{"key":"e_1_2_10_62_1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001230.pub2","article-title":"Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men","author":"Johnson WD","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-1849(05)80025-3"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.89.3.299"},{"issue":"5","key":"e_1_2_10_65_1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/QAI.0000000000001017","article-title":"Impact of peer support on behavior change among newly diagnosed Australian gay men","volume":"72","author":"Prestage G","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.031"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit297"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.08.004"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjia2.25288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.25288","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.25288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T22:32:11Z","timestamp":1694385131000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.25288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1002\/jia2.25288"],"URL":"https:\/\/doi.org\/10.1002\/jia2.25288","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"2018-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e25288"}}